Results 251 to 260 of about 1,541,460 (327)
Diseases of the Nervous System
openaire +3 more sources
Granular Hydrogels as Modular Biomaterials: From Structural Design to Biological Responses
Granular hydrogels are now emerging as promising biomaterials due to their inherent microporousity, injectability, and modularity. They have shown improvements in cell viability and migration, cellular/tissue infiltration, host tissue integration, mitigated foreign body response, and tissue regeneration.
Asmasadat Vaziri +6 more
wiley +1 more source
Oxazole-Based Ferroptosis Inhibitors with Promising Properties to Treat Central Nervous System Diseases. [PDF]
Scarpellini C +12 more
europepmc +1 more source
Seeing inside the Body Using Wearable Sensing and Imaging Technologies
This review explores wearable technologies for noninvasive internal health monitoring. It categorizes approaches into indirect sensing (e.g., bioelectrical and biochemical signals) and direct imaging (e.g., wearable ultrasound and EIT), highlighting multimodal integration and system‐level innovation toward personalized, continuous healthcare.
Sumin Kim +3 more
wiley +1 more source
Mitochondrion-based organellar therapies for central nervous system diseases. [PDF]
Zhao M +6 more
europepmc +1 more source
Current Challenges in Hemostasis and Advances in Particle‐Assisted Styptic Devices
Here persistent limitations in hemostatic technologies are highlighted and cutting‐edge biomimetic, microparticle‐assisted, and nanoengineered systems with integrated drug delivery are showcased. Moreover, the article identifies fresh directions toward the next‐generation of multifunctional hemostatic devices with superior efficacy and accessibility ...
Daniele Baiocco +4 more
wiley +1 more source
Exosomes in Central Nervous System Diseases: A Comprehensive Review of Emerging Research and Clinical Frontiers. [PDF]
Li J +6 more
europepmc +1 more source
Recent advances in diagnostics have accelerated the development of miniaturized wearable technologies for the continuous monitoring of diseases. This paradigm is shifting healthcare away from invasive, centralized blood tests toward decentralized monitoring, using alternative body biofluids.
Lanka Tata Rao +2 more
wiley +1 more source
Neurosurgical gene therapy for central nervous system diseases. [PDF]
Patel RV, Nanda P, Richardson RM.
europepmc +1 more source

